Gene Therapy for Sanfilippo Syndrome Gets FDA Nod

(MedPage Today) -- The FDA on Thursday approved rebisufligene etisparvovec (Fayuvi) as the first treatment for pediatric patients with mucopolysaccharidosis type IIIA (MPS IIIA), also known as Sanfilippo syndrome type A, the agency announced Thursday...